THC Therapeutics, Inc. (THCT)

0.0033 0.0000 (0.00%) At close: 02:32PM EDT

THC Therapeutics, Inc.

11700 W Charleston Blvd.
#73
Las Vegas, NV 89135
United States
833 420 8428
https://thct.io

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 1

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Brandon Romanek	Chief Information Officer, Treasurer, Founder, President, Secretary & Chairman	187.75k	N/A	1975
Mr. Scott A. Cox	CEO, CFO & Director	N/A	N/A	1972
Mr. Victor Nacif	Head of Design	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

THC Therapeutics, Inc. operates in the wellness industry. It engages in the developing of dHydronator, a sanitizing herb dryer for drying and sanitizing of freshly harvested cannabis, other herbs, flowers, and tea leaves. The company was formerly known as Millennium Blockchain, Inc. and changed its name to THC Therapeutics, Inc. in September 2018. THC Therapeutics, Inc. was founded in 2007 and is based in Las Vegas, Nevada.

Corporate governance

THC Therapeutics, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.